Dolores Schendel

Company: Medigene AG

Job title: Chief Scientific Officer

Seminars:

Industry Leaders’ Fireside Chat: What’s Next for T-Cell Receptor Therapies? 8:30 am

Appreciating the wealth of TCR therapy advances and exploring the data to secure clinical validation Examining the range of TCR modalities and their respective targeting benefits Discussing the advances in allogeneic TCR approaches to determine the future directions for TCR therapiesRead more

day: Conference Day One

Case Study Spotlight: Introducing Innovations at Each Step of TCR Therapy Development 9:30 am

Effective, specific and safe antigen identification using an in silico screening program to knock out unwanted epitopes Utilizing a high throughput robotics platform to find donor TCRs for any antigen/ HLA combination Creating enhanced inducible TCR products with precision pairing technology and switch receptors to arm against the tumor microenvironmentRead more

day: Conference Day One